Biopharm Assets is an European Consulting company focused on Asset Management and business development in the Life Science • We focus on international business development for pharmaceuticals, biotech, health, beauty and personal care consumer products – a consulting company. • European and MENA markets coverage with a wide knowledge of the local markets • A company fully oriented to B2B with a strong sense of the Business management • An external resource that helps you to reach project targets and meet expectations maximizing value
| Website | http://biopharmassets.com/ |
| Revenue | $5 million |
| Employees | 1 (0 on RocketReach) |
| Founded | 2011 |
| Phone | +34 663 84 67 31 |
| Technologies | |
| Industry | Pharmaceutical Manufacturing, Business Services General, Business Services |
| Keywords | Life Science Consulting, Business Development Life Sciences, Asset Management Consulting, Pharmaceutical Business Development, Strategic Asset Management, International Business Development, Biotech Business Development, Global Business Development, Biotech Consulting, Health Consulting, Personal Care Consulting, Beauty Consulting, Consumer Products Consulting |
| Competitors | Novartis, Pfizer, Amgen, Regeneron, Gilead Sciences, Vertex Pharmaceuticals, Biogen, Alnylam Pharmaceuticals, Sangamo Therapeutics, Inc., Akcea Therapeutics +46 more (view full list) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies |
Looking for a particular Biopharm Assets employee's phone or email?
The Biopharm Assets annual revenue was $5 million in 2026.
The NAICS codes for Biopharm Assets are [541, 541713, 54171, 54, 5417].
The SIC codes for Biopharm Assets are [873, 87].